Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage
Open Access
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 35 (3), 327-339
- https://doi.org/10.1016/j.molcel.2009.06.036
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Human CtIP promotes DNA end resectionNature, 2007
- Cdk1 is sufficient to drive the mammalian cell cycleNature, 2007
- Combined Depletion of Cell Cycle and Transcriptional Cyclin-Dependent Kinase Activities Induces Apoptosis in Cancer CellsCancer Research, 2006
- Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1Proceedings of the National Academy of Sciences, 2006
- Unmasking the Redundancy Between Cdk1 and Cdk2 at G2 Phase in Human Cancer Cell LinesCell Cycle, 2006
- BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious MutantsCancer Research, 2006
- AZ703, an Imidazo[1,2-a]Pyridine Inhibitor of Cyclin-Dependent Kinases 1 and 2, Induces E2F-1-Dependent Apoptosis Enhanced by Depletion of Cyclin-Dependent Kinase 9Cancer Research, 2006
- DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1Nature, 2004
- BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damageNature Genetics, 2002
- Mouse Brca1: localization, sequence analysis and identification of evolutionarily conserved domainsHuman Molecular Genetics, 1995